Free Trial
NASDAQ:RKDA

Arcadia Biosciences (RKDA) Stock Price, News & Analysis

Arcadia Biosciences logo
$4.45 -0.09 (-1.98%)
Closing price 04:00 PM Eastern
Extended Trading
$4.38 -0.08 (-1.69%)
As of 05:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Arcadia Biosciences Stock (NASDAQ:RKDA)

Key Stats

Today's Range
$4.36
$4.60
50-Day Range
$3.87
$5.10
52-Week Range
$2.40
$10.31
Volume
2,944 shs
Average Volume
310,123 shs
Market Capitalization
$6.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Buy

Company Overview

Arcadia Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

RKDA MarketRank™: 

Arcadia Biosciences scored higher than 53% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Arcadia Biosciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Arcadia Biosciences has received no research coverage in the past 90 days.

  • Read more about Arcadia Biosciences' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Arcadia Biosciences is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Arcadia Biosciences is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Arcadia Biosciences has a P/B Ratio of 0.98. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Arcadia Biosciences' valuation and earnings.
  • Percentage of Shares Shorted

    1.69% of the float of Arcadia Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Arcadia Biosciences has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Arcadia Biosciences has recently increased by 3.14%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Arcadia Biosciences does not currently pay a dividend.

  • Dividend Growth

    Arcadia Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.69% of the float of Arcadia Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Arcadia Biosciences has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Arcadia Biosciences has recently increased by 3.14%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Arcadia Biosciences has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.96 average news sentiment score of Medical companies.
  • Search Interest

    3 people have searched for RKDA on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Arcadia Biosciences to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Arcadia Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.80% of the stock of Arcadia Biosciences is held by insiders.

  • Percentage Held by Institutions

    Only 17.73% of the stock of Arcadia Biosciences is held by institutions.

  • Read more about Arcadia Biosciences' insider trading history.
Receive RKDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arcadia Biosciences and its competitors with MarketBeat's FREE daily newsletter.

RKDA Stock News Headlines

RKDA Arcadia Biosciences, Inc.
Missed the Run So Far? This Is Your Second Chance
According to history, the final stretch of the crypto cycle is here — and this short window is where fortunes are made. Inside The Crypto Code Workshop, two experts reveal how to get positioned early, lock in profits, and access their top altcoin picks before the crowd. All attendees receive $10 in free Bitcoin just for showing up.
Arcadia Climbs on Q1 Figures
See More Headlines

RKDA Stock Analysis - Frequently Asked Questions

Arcadia Biosciences' stock was trading at $5.92 at the start of the year. Since then, RKDA stock has decreased by 24.8% and is now trading at $4.45.

Arcadia Biosciences, Inc. (NASDAQ:RKDA) posted its quarterly earnings data on Thursday, May, 8th. The basic materials company reported $1.90 earnings per share for the quarter, topping analysts' consensus estimates of ($0.98) by $2.88. The basic materials company earned $1.20 million during the quarter, compared to analyst estimates of $1.60 million. Arcadia Biosciences had a negative trailing twelve-month return on equity of 16.94% and a negative net margin of 38.34%.
Read the conference call transcript
.

Arcadia Biosciences shares reverse split before market open on Wednesday, January 24th 2018.The 1-20 reverse split was announced on Tuesday, January 23rd 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 23rd 2018. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Arcadia Biosciences (RKDA) raised $66 million in an IPO on Friday, May 15th 2015. The company issued 8,200,000 shares at $8.00 per share. Credit Suisse, J.P. Morgan and Piper Jaffray acted as the underwriters for the IPO.

Shares of RKDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arcadia Biosciences investors own include NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), GE Aerospace (GE), Arista Networks (ANET), Advanced Micro Devices (AMD) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
5/08/2025
Today
7/18/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Agriculture
Current Symbol
NASDAQ:RKDA
CIK
1469443
Employees
60
Year Founded
N/A

Price Target and Rating

High Price Target
$6.00
Low Price Target
$6.00
Potential Upside/Downside
+35.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.28)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.04 million
Net Margins
-38.34%
Pretax Margin
-14.51%
Return on Equity
-16.94%
Return on Assets
-10.56%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.99
Quick Ratio
3.41

Sales & Book Value

Annual Sales
$5.05 million
Price / Sales
1.20
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.56 per share
Price / Book
0.97

Miscellaneous

Outstanding Shares
1,370,000
Free Float
1,342,000
Market Cap
$6.07 million
Optionable
Not Optionable
Beta
0.50

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:RKDA) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners